Stockreport

Progenics Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Update

PROGENICS PHARMACEUTICALS  (PGNX) 
Last progenics pharmaceuticals earnings: 8/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: progenics.com
PDF NDA (New Drug Application) for AZEDRA® (iobenguane I 131) Submitted to the U.S. Food and Drug Administration (FDA) on October 31stPositive Results from the Pivotal Phase [Read more]